Members of the US Congress are upping the pressure on the Centers for Medicare and Medicaid Services (CMS) to fully enact a program that will allow swifter coverage of medical devices cleared via the Food and Drug Administration’s breakthrough pathway.
The program, Medicare Coverage for Innovative Technology (MCIT), would require the CMS to reimburse for breakthrough devices for at least four years from the date of FDA authorization. It was...
In particular, the agency expressed concerns about billing codes for the new devices, as well as the potential for more devices to be eligible for the program than originally anticipated....
